Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 24, 2025 02:42 ET | Source: Burning Rock Biotech Limited

Burning Rock's OncoGuide™ OncoScreen™ Plus CDx System Now Approved in Japan as a Companion Diagnostic for Capivasertib in Breast Cancer

Burning Rock's OncoGuide™ OncoScreen™ Plus CDx System Now Approved in Japan as a Companion Diagnostic for Capivasertib in Breast Cancer
September 23, 2025 08:00 ET | Source: Myriad Genetics, Inc.

Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy

SALT LAKE CITY and BOSTON, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics (Nasdaq: MYGN), a leader in molecular diagnostic testing and precision medicine, and SOPHiA GENETICS (Nasdaq: SOPH), an...
March 04, 2025 07:28 ET | Source: Research and Markets

Cell Free RNA Diagnostics Market Research 2025-2035: Trends Shaping the Market and Growth Projections by Product Type, Sample, Application, Technology, and Geography with Profiles of the Major Competitors

Dublin, March 04, 2025 (GLOBE NEWSWIRE) -- The "Cell Free RNA Diagnostics Market, 2025-2035: Focus on Product Type, Sample, Application, Technology, and Geography" report has been added to ...
January 14, 2025 04:34 ET | Source: Research and Markets

Top 6 Growth Opportunities for Clinical Diagnostics in 2025: LIMS, NGS Informatics, Smart Lab Solutions, CDx, Neurology Blood Tests, and Rapid Antimicrobial Resistance Diagnostics

Dublin, Jan. 14, 2025 (GLOBE NEWSWIRE) -- The "Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025" report has been added to ResearchAndMarkets.com's offering.Accounting for 2%-3% of...
January 10, 2025 06:51 ET | Source: Research and Markets

$26+ Billion Exocrine Pancreatic Insufficiency (EPI) Diagnostics Market Forecast, 2034 - Cystic Fibrosis Drives Revenue, with High Prevalence Sparking Demand for Advanced Testing

Dublin, Jan. 10, 2025 (GLOBE NEWSWIRE) -- The "Exocrine Pancreatic Insufficiency Diagnostics Market by Diagnostic Method, by Application, by End-User, and by Region" report has been added to ...
October 09, 2024 09:00 ET | Source: SNS Insider pvt ltd

Companion Diagnostics Market Size Worth US$ 21.15 billion by 2032, Rising Prevalence of Cancer and Advances in Precision Medicine Drives Growth | Research by SNS Insider

Pune, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Companion Diagnostics Market Size Analysis: “According to SNS Insider Research, The Companion Diagnostics Market Size was valued at USD 7.66 Billion in 2023,...
September 19, 2024 11:10 ET | Source: Research and Markets

Companion Diagnostics (CDx) Market - Global Forecasts from 2024 to 2029

Dublin, Sept. 19, 2024 (GLOBE NEWSWIRE) -- The "Companion Diagnostics (CDx) Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.com's offering.The companion...
February 19, 2024 04:26 ET | Source: Research and Markets

Precision Diagnostics and Testing Technology Advancements: Innovation is Driving the Era of Value-based Care and Enabling Preventive and Personalized Health

Dublin, Feb. 19, 2024 (GLOBE NEWSWIRE) -- The "Technology Advancements in Precision Diagnostics and Testing" report has been added to ResearchAndMarkets.com's offering. Precision diagnosis in...
February 12, 2024 04:38 ET | Source: Research and Markets

Companion Diagnostics (CDx) Market Forecast to Surpass $6.5 Billion by End of 2024 with Continued Growth Expected Through 2034

Dublin, Feb. 12, 2024 (GLOBE NEWSWIRE) -- The "Companion Diagnostics (CDx) Market Report 2024-2034" has been added to ResearchAndMarkets.com's offering.World revenue for Companion Diagnostics (CDx)...
July 06, 2022 05:43 ET | Source: Research and Markets

Global Liquid Biopsy Market Predicted to Surpass US$ 11 Billion by 2030

Dublin, July 06, 2022 (GLOBE NEWSWIRE) -- The "Global Liquid Biopsy Market, Impact of COVID-19, Initiatives, Funding, Major Deals, Company Profiles and Recent Developments - Forecast to 2030" report...